Chasteberry shows some promise for reducing menopause symptoms like hot flashes and anxiety, but the evidence is limited and major medical organizations don’t currently recommend it. In one randomized trial, women taking chasteberry saw their vasomotor symptom scores drop by roughly 88% compared to a 28% drop in the placebo group. That’s an encouraging result, but the overall body of research remains small, and chasteberry has been studied far more extensively for premenstrual symptoms than for menopause.
How Chasteberry Works in the Body
Chasteberry contains compounds called diterpenes that activate dopamine receptors in the pituitary gland, the small structure at the base of the brain that controls many hormonal signals. By stimulating these receptors, chasteberry suppresses the release of prolactin, a hormone that can interfere with the balance of estrogen and progesterone. In premenopausal women, this effect has been shown to normalize low progesterone levels. One placebo-controlled study found that mid-cycle progesterone levels significantly improved after chasteberry supplementation.
During menopause, however, progesterone and estrogen are declining for different reasons: the ovaries are winding down production permanently. This is an important distinction. Most of the hormonal research on chasteberry was conducted in women who still had menstrual cycles. Whether the same dopamine-driven mechanism provides meaningful hormonal support after menopause is less clear, and that gap in the research matters.
What the Clinical Evidence Shows
A randomized, double-blind trial published in the Korean Journal of Family Medicine compared chasteberry extract with placebo in menopausal women over an eight-week period. Before treatment, the two groups had nearly identical vasomotor symptom scores (around 3.7 on a standardized scale). After eight weeks, the chasteberry group dropped to 0.46 while the placebo group remained at 2.72. That difference was statistically significant.
The same trial found that anxiety scores improved roughly 3.2 times more in the chasteberry group than in the placebo group, and overall menopausal symptom scores improved about 3 times more. Both results were highly significant statistically. However, one detail stands out: when researchers looked specifically at the number of hot flashes per day rather than symptom severity scores, the difference between groups wasn’t significant. Women in the chasteberry group averaged about 8.6 hot flashes per day and those on placebo averaged about 9.2. So chasteberry may reduce how bothersome hot flashes feel without dramatically changing how often they occur.
How It Compares to Other Herbal Options
Among herbal supplements studied for menopause, black cohosh and red clover have the strongest and most consistent evidence. A 2021 review in the journal Molecules noted that both were “consistently shown to help reduce menopausal symptoms in clinical studies,” while chasteberry’s strongest evidence base remains in premenstrual syndrome rather than menopause. That doesn’t mean chasteberry is ineffective for menopause, but it does mean other herbal options have been tested more thoroughly for this specific use.
The North American Menopause Society’s 2023 position statement on nonhormone therapies did not recommend herbal supplements, including chasteberry, for managing vasomotor symptoms. The organization categorized all supplements and herbal remedies as “not recommended” based on the current level of evidence. This reflects the limited number of large, well-designed trials rather than evidence of harm.
Typical Dosage and Timeline
Clinical studies have used a range of doses. The most common standardized dose is 4 mg per day of an extract containing 6% agnuside, which is the marker compound used to ensure consistency between products. Unstandardized fruit extracts have been used at 20 to 40 mg per day, and some studies have tested doses as high as 1,800 mg per day.
The eight-week trial in menopausal women is the best reference point for how long it takes to see results. Significant differences in vasomotor and anxiety scores emerged by the end of that period. For premenstrual symptoms, most studies show benefits within two to three menstrual cycles, which suggests chasteberry generally needs at least four to eight weeks of consistent daily use before producing noticeable changes. If you’re trying it, giving it less than a month isn’t a fair test.
Side Effects and Safety Concerns
Chasteberry is generally well tolerated. The most commonly reported side effects are mild: nausea, stomach discomfort, diarrhea, headache, and itching. Serious adverse effects are rare in the published literature.
The more important concern is for women with hormone-sensitive conditions. Because chasteberry influences prolactin, estrogen, and progesterone levels, the National Institutes of Health flags it as potentially unsafe for women with a history of breast, uterine, or ovarian cancer. It’s also considered potentially unsafe during pregnancy or breastfeeding. And because it acts on dopamine receptors, it can interact with medications that affect the same pathway, including certain psychiatric medications and drugs used for Parkinson’s disease.
The Bottom Line on Chasteberry and Menopause
The limited trial data suggests chasteberry can reduce the severity of hot flashes, lower anxiety, and improve overall menopause symptom scores compared to placebo. But “limited” is the key word. Most of chasteberry’s research reputation comes from premenstrual syndrome, where it has much stronger support. For menopause specifically, we’re working from a small number of trials with relatively few participants. If you’re looking for an herbal option with a deeper evidence base for menopause symptoms, black cohosh has been studied more extensively. If you’re drawn to chasteberry because it helped with PMS earlier in life, the existing research suggests it may offer some benefit during menopause too, particularly for the severity of vasomotor symptoms and anxiety.